| * Stem cell-ness: a "magic marker" for cancer |
| * In vivo correction of ZAP-70 immunodeficiency by intrathymic gene transfer |
| * Intensive insulin therapy protects the endothelium of critically ill patients |
| * Natural peptides selected by diabetogenic DQ8 and murine I-Ag7 molecules show common sequence specificity |
| * Autoantigen, innate immunity, and T cells cooperate to break B cell tolerance during bacterial infection |
| * PPAR regulates adipocyte cholesterol metabolism via oxidized LDL receptor 1 |
| * Induction of mucosal tolerance in Peyer‘s patch‘deficient, ligated small bowel loops |
| * The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages |
| * Rap1b is required for normal platelet function and hemostasis in mice |
| * The cytoskeletal protein ezrin regulates EC proliferation and angiogenesis via TNF-–induced transcriptional repression of cyclin A |
| * Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase-1 |
| * HIV-1 fusion peptide targets the TCR and inhibits antigen-specific T cell activation |
| * Saturated fat–rich diet enhances selective uptake of LDL cholesteryl esters in the arterial wall |
| * Human cardiac potassium channel DNA polymorphism modulates access to drug-binding site and causes drug resistance |
| * Impaired negative feedback suppression of bile acid synthesis in mice lacking ?Klotho |
| * ROS generated by pollen NADPH oxidase provide a signal that augments antigen-induced allergic airway inflammation |
| * Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice |
| * ROS generated by pollen NADPH oxidase provide a signal that augments antigen-induced allergic airway inflammation |
| * A mouse model of juvenile hemochromatosis |
| * Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload |
| * The AML1-ETO fusion gene and the FLT3 length mutation collaborate in inducing acute leukemia in mice |
| * Enzymatic function of hemoglobin as a nitrite reductase that produces NO under allosteric control |
| * The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis |
| * Akt1/protein kinase B is critical for ischemic and VEGF-mediated angiogenesis |
| * Induction of prolonged survival of CD4+ T lymphocytes by intermittent IL-2 therapy in HIV-infected patients |
| * PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury |
| * Enzymatic function of hemoglobin as a nitrite reductase that produces NO under allosteric control |
| * Akt1/protein kinase B is critical for ischemic and VEGF-mediated angiogenesis |
| * The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis |
| * Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure |
| * Weaving ?Klotho into bile acid metabolism |
| * A molecule’s right to choose: how diabetogenic class II MHC products bind peptides |
| * You are right too! |
| * Insulin infusion in acute illness |
| * Spring brings breezes, wheezes, and pollen oxidases |
| * A new direction for gene therapy: intrathymic T cell–specific lentiviral gene transfer |
| * Akt1 in the cardiovascular system: friend or foe? |
| * Of mice and men: the iron age |
| * ATP-sensitive potassium channelopathies: focus on insulin secretion |
| * Chloride channel diseases resulting from impaired transepithelial transport or vesicular function |
| * Cardiac and skeletal muscle disorders caused by mutations in the intracellular Ca2+ release channels |
| * Genetics of acquired long QT syndrome |
| * Long QT syndrome: from channels to cardiac arrhythmias |
| * Sodium channel mutations in epilepsy and other neurological disorders |
| * Muscle channelopathies and critical points in functional and genetic studies |
| * Inherited disorders of voltage-gated sodium channels |
| * The channelopathies: novel insights into molecular and genetic mechanisms of human disease |
| * Thyrotropin receptor–associated diseases: from adenomata to Graves disease |
| * Splendid solution Jonas Salk and the conquest of polio |
| * Message in a bottle The making of fetal alcohol syndrome |
| * Stopping stroke before it strikes |
| * New Annie and Willie Nelson Professor says award is music to his ears |
| * A catalyst of the bioengineering field plans its farewell |
| * Tom Cruise is dangerous and irresponsible |
| * In this issue |
| * IV cyclophosphamide bodes well for neuropsychiatric SLE |
| * Sir Thomas Lewis 1881–1945 |
| * Ventriculitis and hydrocephalus: an unusual presentation of toxoplasmosis in an adult with human immunodeficiency virus |
| * Cranial neuroimaging and clinical neuroanatomy |
| * The A–Z of neurological practice. A guide to clinical neurology |
| * Spinal muscular atrophy, Dandy-Walker complex, and cataracts in two siblings: a new entity? |
| * Cerebral sinus thrombosis in a patient with Cushing’s syndrome |
| * Quality of life after decompressive craniectomy for malignant middle cerebral artery infarction |
| * Transient short free running circadian rhythm in a case of aneurysm near the suprachiasmatic nuclei |
| * Outcomes of incident mild cognitive impairment in relation to case definition |
| * Optic flow induced nystagmus |
| * Ability of a nurse specialist to diagnose simple headache disorders compared with consultant neurologists |
| * A diagnostic test of unawareness of bilateral motor task abilities in anosognosia for hemiplegia |
| * Is dementia reversible in patients with neurocysticercosis? |
| * The first evaluation of brain shift during functional neurosurgery by deformation field analysis |
| * Occipital activation in glyceryl trinitrate induced migraine with visual aura |
| * Evaluation of preoperative high magnetic field motor functional MRI (3 Tesla) in glioma patients by navigated electrocortical stimulation an |
| * Whiplash following rear end collisions: a prospective cohort study |
| * Brief cognitive assessment for patients with cerebral small vessel disease |
| * Impact of pyrexia on neurochemistry and cerebral oxygenation after acute brain injury |
| * Inflammatory markers, rather than conventional risk factors, are different between carotid and MCA atherosclerosis |
| * A syndromal analysis of neuropsychological outcome following coronary artery bypass graft surgery |
| * Intractable chronic inflammatory demyelinating polyneuropathy treated successfully with ciclosporin |
| * Age associated axonal features in HNPP with 17p11.2 deletion in Japan |
| * Quantitative MRI of the wrist and nerve conduction studies in patients with idiopathic carpal tunnel syndrome |
| * The features of myasthenia gravis with autoantibodies to MuSK |
| * Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study |
| * Brain energy metabolism and intracranial pressure in idiopathic adult hydrocephalus syndrome |
| * Headache as the only neurological sign of cerebral venous thrombosis: a series of 17 cases |
| * Cognitive performance of patients with mesial temporal lobe epilepsy and incidental calcified neurocysticercosis |
| * Cognitive performance after first ever stroke related to progression of vascular brain damage: a 2 year follow up CT scan study |
| * On the overlap between apathy and depression in dementia |
| * Neurophysiological predictors of long term response to AChE inhibitors in AD patients |
| * Neurodegenerative disorders: Parkinson’s disease and Huntington’s disease |
| * Molecular and cellular pathways of neurodegeneration in motor neurone disease |
| * Does the risk factor profile have predictive value for the site of atherosclerosis? |
| * Whiplash injury may deregulate the biological clock |
| * Cerebral venous thrombosis – headache is enough |